RSV specific binding molecule
US9283274B2 · kind B2 · utility
9Cited by
112References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2013 |
| Grant date | Mar 15, 2016 |
| Priority date | — |
| Expiry date | Nov 29, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides antibodies and functional equivalents thereof which are capable of specifically binding RSV. Nucleic acid sequences encoding said antibody, as well as antibody producing cells and methods for producing said antibody are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.